Article Details
Retrieved on: 2024-11-04 05:07:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In July 2020, Roche's Genentech inked a collaboration with UCB to develop an anti-tau antibody treatment, bepranemab (UCB0107) for Alzheimer's disease ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here